Recent News +++


Media Relations by PCCTC May 26, 2023

Fulfilling our mission of translating scientific discoveries to improved standards of care...

Learn More

Bipolar Androgen Therapy for Patients Who Have Progressed on Abiraterone

Media Relations by PCCTC February 26, 2021

Led by Dr. Samuel R. Denmeade and his team at Johns Hopkins School of Medicine – Sid...

Learn More

CCC19 Registry Launched to Understand COVID-19 in Patients with Cancer

Media Relations by Hannah Slater via CancerNetwork March 27, 2020

All are encouraged to participate to quickly gather details related to patients with cance...

Learn More

Dr. Dana Rathkopf Discusses IRONMAN Registry with UroToday

Media Relations by PCCTC February 12, 2020

IRONMAN – An International Registry for Men with Advanced Prostate Cancer.

Learn More

PCCTC Investigators Author Key Paper on Liquid Biopsy Data

Media Relations by PCCTC February 4, 2020

Effort organized by BloodPAC describes minimum technical data elements for liquid biopsy d...

Learn More

Prostate Cancer ABCs Presents Patient and Caregiver Conference

Media Relations by PCCTC January 23, 2020

Free event featuring PCCTC advocates Jan Manarite and Joel Nowak will take place Saturday,...

Learn More

Phase I DSTP3086S Trial Results Published

Media Relations by PCCTC November 11, 2019

PCCTC study demonstrates safety and antitumor activity of humanized immunoglobulin G1 anti...

Learn More

Advocacy Symposium Led by PCCTC Investigator

Media Relations by PCCTC August 10, 2018

Dr. Elisabeth Heath of Karmanos Cancer Institute will head up the 8th Annual Prostate Canc...

Learn More

Blood Test Predicts Treatment Response, Survival in Metastatic Disease

Media Relations by PCCTC June 29, 2018

PCCTC Scientific Oversight Committee Chair, Howard I. Scher, MD leads international study....

Learn More

The PCCTC Is Expanding Its Trial Management Capabilities

Media Relations by PCCTC June 12, 2018

To better meet the needs of our partners the PCCTC is expanding its infrastructure. Our ce...

Learn More

Early Development Led by the PCCTC, FDA Approval Now Sought for Apalutamide

Media Relations by Jason Harris - OncLive October 12, 2017

A new drug application (NDA) has been submitted to the FDA for apalutamide (ARN-509) for t...

Learn More

Team PCCTC Joins Movember Effort

Media Relations by PCCTC November 1, 2016

Prostate cancer is the second most common cancer in men worldwide. The PCCTC and Movember ...

Learn More
View More News +

Follow Us

Join our team of dedicated clinical research professionals! The Prostate Cancer Clinical Trials Consortium is currently seeking a Quality Manager and Clinical Data Manager to help fulfill our…

2018-23944 Clinical Data Manager, Prostate Cancer Clinical Trials Consortium (PCCTC) | Memorial Sloan Kettering Cancer Center Careers

Committed to world-class science!

Our services translate scientific discoveries into improved standards of care, ensuring efficient trial selection, reporting, site management, clinical operations and data analyses.